influenza, vaccination, cost-effectiveness, economic evaluation, universal vaccines, next generation vaccines, mathematical modelling
influenza, covid-19, sars-cov-2, sequencing
Ebola virus disease, Ebola, vaccine, rVSV-ZEBOV, safety, immunogenicity, cohort study
COVID-19, equity, social protection